ERBB2 and breast cancer: Importantly, in all of the ER-positive, HER2-normal, or aberrant BC cell lines analyzed, it was demonstrated that metformin inhibits Akt and mTOR pathways, resulting in the inhibition of cellular proliferation, colony formation, and G1 phase cell cycle arrest [48,49].